Results 31 to 40 of about 40,781 (258)

Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui   +10 more
wiley   +1 more source

Severe acute hepatitis in a person with HIV and simultaneous infection with hepatitis C virus and SARS-CoV-2. [PDF]

open access: yesEnferm Infecc Microbiol Clin (Engl Ed), 2023
Santos M   +3 more
europepmc   +2 more sources

Hepatitis C

open access: yesActa Médica Peruana, 2012
La Hepatitis C es una enfermedad hepática causada por el virus de la hepatitis C (VHC). Esta entidad se ha convertido en un problema de salud pública universal y se considera que cerca de 150 millones de personas están crónicamente infectada por el ...
César Soriano Álvarez
doaj  

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

La atención primaria en el control de un brote de hepatitis en un círculo infantil Primary health care in the control of an outbreak of hepatitis in a day care center

open access: yesRevista Cubana de Investigaciones Biomédicas, 2006
Se realizó un control de foco de hepatitis aguda en un círculo infantil, estudiando 118 niños y 37 trabajadores, mediante encuestas epidemiológicas, exámenes físicos y toma de muestras para: transaminasa glutámico pirúvico; dosificaciones de ...
Ricardo Almeida Varela   +2 more
doaj  

Evaluación de diferentes péptidos de la región estructural del virus de la hepatitis C

open access: yesBiomédica: revista del Instituto Nacional de Salud, 2001
Para el diagnóstico del virus de la hepatitis C, se utilizan ampliamente las pruebas de Elisa por su sensibilidad y especificidad. Gran parte de ellos se basa en el empleo de péptidos sintéticos.
lvonne Gómez   +4 more
doaj   +1 more source

Vigilancia activa de enfermedades infecciosas en donantes de sangre Active surveillance of infectious diseases in blood donors

open access: yesRevista Cubana de Hematología, Inmunología y Hemoterapia, 2013
En Cuba es de carácter obligatorio realizar al 100% de la sangre donada, pruebas de laboratorio para detectar anticuerpos contra los Virus de Inmunodeficiencia Humana 1 y 2 (VIH), antígeno de superficie del Virus de la Hepatitis B (VHB), anticuerpos ...
Pedro Sánchez-Frenes   +3 more
doaj  

The Development of Rheumatoid Arthritis–Specific Ambulatory Care–Sensitive Conditions: Results of a Consensus Process

open access: yesArthritis Care &Research, EarlyView.
Objective Ambulatory care–sensitive conditions (ACSCs) serve as indicators of access, quality, and performance of the health system. This study aimed to determine rheumatoid arthritis (RA)‐specific ACSCs for use in the evaluation of care system access and quality.
Kara Irwin   +7 more
wiley   +1 more source

Hepatitis crónicas virales B y C en población inmigrante en España

open access: yesRevista Española de Salud Pública, 2014
Fundamentos: En España la prevalencia de la hepatitis crónicas de origen viral puede variar a causa de los inmigrantes procedentes de áreas de elevada prevalencia de infección por virus B y C de la hepatitis.
Enrique Calderón Sandubete   +5 more
doaj  

Real‐World Safety of Concomitant Colchicine and Statin Therapy

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the risk of clinically meaningful muscle‐ and liver‐related outcomes associated with concomitant colchicine–statin therapy in a real‐world setting, and to determine whether concomitant therapy increases the incidence of toxicity compared with either agent alone.
Roni Meidan   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy